News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BioClinica, Inc. Announces Availability of Express EDCplus


4/22/2013 11:16:22 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

NEWTOWN, Pa., April 22, 2013 /PRNewswire/ -- BioClinica®, Inc., a global provider of clinical trial management services, today announced the immediate availability of BioClinica Express EDCplus. Through the web-based EDCplus program, sponsors and CROs personnel can now directly build their own Express EDC (electronic data capture) studies. The program offers full access to the same system that BioClinica created to build thousands of studies over 15 years, without compromising on power or performance.

(Logo: http://photos.prnewswire.com/prnh/20130403/PH87647LOGO )

Express EDCplus is a comprehensive EDC "technology transfer" program. It helps organizations exert greater control over the development and implementation timelines of the technology they use to support their clinical trials. The technology behind Express EDCplus was designed with extensive input from customers and data managers to allow non-technical research personnel to create and run studies with little or no programming effort.

"Express EDCplus has the potential to change the way sponsors and CROs use technology to run clinical trials," said Peter Benton, eClinical President of BioClinica. "Unlike other alternatives, our system is easy to use, has the power to support the most complex studies, and offers significant savings for customers. Express EDCplus lets designers take their trials from test to live in seconds with just one click and allows for easy, inexpensive mid-study changes. Our study builder tool enables complex scenarios such as risk-based monitoring schedules, automated design validation rules that reduce the effort required to manage quality, and provides extensive support for corporate or industry standard design libraries."

Express EDCplus will also deliver the same superior support and guidance associated with traditional Express studies. Every study has dedicated support contacts to help develop plans and support the study build process. Training is a central element of the program which includes flexible training models to fit the needs of different sponsors and CROs.

BioClinica will demonstrate Express EDCplus at the 22nd Annual Partnerships in Clinical Trials conference, #513, from April 21 through 24 in Orlando, Florida.

Follow BioClinica on the Trial Blazers blog at http://www.bioclinica.com/blog, and on twitter at http://twitter.com/bioclinica.

About BioClinica, Inc.
BioClinica, Inc. is a global provider of integrated, technology-enhanced clinical trial management services. The 2013 merger with CoreLab Partners created a new leader in imaging core lab services including electronic transfer, management, and independent review; cardiovascular safety monitoring including automated ECG, Thorough QT studies, Holter monitoring, ambulatory blood pressure monitoring and pulse wave analysis; and eClinical solutions for electronic data capture, randomization, clinical trial management, and clinical supply chain forecasting and optimization. BioClinica offers unmatched scientific expertise with a team of respected medical researchers and board certified, sub-specialty trained radiologists, cardiologists, nuclear medicine physicians and oncologists. With more than 28 years of experience and over 3000 successful trials to date, BioClinica has supported the development of many new medicines through all phases of the clinical trial process. BioClinica operates state-of-the-art, regulatory-body-compliant imaging core labs on two continents, and supports worldwide comprehensive cardiovascular safety, and eClinical and data management services from offices in the United States, Europe and Asia. For more information, please visit www.bioclinica.com.

SOURCE BioClinica, Inc.



Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES